Zi Jun Emma Wang, PhD

Chief Technology Officer at YolTech Therapeutics

Speaker

Dr. Emma Wang is the chief technology offer and co-founder at YolTech Therapeutics. Her focus is on advancing the non-viral delivery platform to support in vivo gene therapy development through research in novel lipid discovery, product development, process development, characterization as well as GMP manufacture. Prior to joining YolTech, Emma held research positions of growing responsibilities at Providence Therapeutics and Beam Therapeutics. Emma holds a Ph.D. in Chemistry as a member of Prof. Katharina Landfester's group from Max Planck Institute for Polymer Research in Germany, a M.Eng and B.Eng in Chemical Engineering from McGill University in Canada.